Credit Suisse Downgrades St. Jude Medical (STJ) to Neutral Follower Takeout

Go back to Credit Suisse Downgrades St. Jude Medical (STJ) to Neutral Follower Takeout

Morgan Stanley Downgrades St. Jude Medical (STJ) to Equalweight

May 2, 2016 9:29 AM EDT

Morgan Stanley downgraded St. Jude Medical (NYSE: STJ) from Overweight to Equalweight with a price target of $81.00 (from $67.00).

For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.

Shares of St. Jude Medical closed at $76.20 yesterday.

... More

Needham & Company Downgrades St. Jude Medical (STJ) to Hold Following Takeover

April 29, 2016 7:15 AM EDT

Needham & Company downgraded St. Jude Medical (NYSE: STJ) from Buy to Hold after the company agreed to be acquired by Abbott.

Analyst Mike Matson commented, "After Abbott (ABT) denied a report last summer in the Financial Times that it was... More

William Blair Downgrades St. Jude Medical (STJ) to Market Perform

April 29, 2016 7:10 AM EDT

William Blair downgraded St. Jude Medical (NYSE: STJ) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.

Shares of St. Jude Medical closed at $77.79 yesterday.

... More